Femasys Inc (FEMY)

Currency in USD
0.9687
+0.1604(+19.84%)
Closed·
After Hours
0.9127-0.0560(-5.78%)
·
FEMY Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Unusual Post-Market activity
Fair Value
Day's Range
0.80601.0000
52 wk Range
0.69301.8000
Key Statistics
Prev. Close
0.8083
Open
0.806
Day's Range
0.806-1
52 wk Range
0.693-1.8
Volume
516.91K
Average Volume (3m)
297.62K
1-Year Change
-23.02%
Book Value / Share
0.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FEMY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.2500
Upside
+648.43%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Femasys Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Femasys Inc Company Profile

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Compare FEMY to Peers and Sector

Metrics to compare
FEMY
Peers
Sector
Relationship
P/E Ratio
−1.2x−5.8x−0.5x
PEG Ratio
0.13−0.290.00
Price/Book
13.2x2.3x2.6x
Price / LTM Sales
15.5x5.9x3.3x
Upside (Analyst Target)
-15.2%43.5%
Fair Value Upside
Unlock3.5%6.3%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.2500
(+648.43% Upside)

Earnings

Latest Release
May 09, 2025
EPS / Forecast
-0.23 / -0.19
Revenue / Forecast
341.26K / 1.38M
EPS Revisions
Last 90 days

FEMY Income Statement

People Also Watch

1.810
IPA
-1.09%
4.210
UNCY
+0.48%
2.565
CRDF
+2.19%
2.9800
SNGX
-4.18%

FAQ

What Stock Exchange Does Femasys Trade On?

Femasys is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Femasys?

The stock symbol for Femasys is "FEMY."

What Is the Femasys Market Cap?

As of today, Femasys market cap is 32.20M.

What Is Femasys's Earnings Per Share (TTM)?

The Femasys EPS (TTM) is -0.91.

When Is the Next Femasys Earnings Date?

Femasys will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is FEMY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Femasys Stock Split?

Femasys has split 0 times.

How Many Employees Does Femasys Have?

Femasys has 70 employees.

What is the current trading status of Femasys (FEMY)?

As of 05 Aug 2025, Femasys (FEMY) is trading at a price of 0.97, with a previous close of 0.81. The stock has fluctuated within a day range of 0.81 to 1.00, while its 52-week range spans from 0.69 to 1.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.